organization · Reporting owner
Insight Venture Partners (Cayman) X, L.P.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hinge Health, Inc.
Report date July 07, 2026 · Filed July 10, 2026
Jointly reported with Insight Holdings Group, LLC, Insight Venture Associates X, L.P., Insight Venture Associates X, Ltd., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X (Co-Investors), L.P., Insight Venture Partners X, L.P.
Section 16 reporting ended · disclosed 2026-07-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 122,188 |
Reported balance
After 2026-07-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-07-07 · Conversion · Acquired 122,188 · Balance 122,188 F8: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 2,907 |
Reported balance
After 2026-07-07 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-07-07 · Conversion · Acquired 2,907 · Balance 2,907 F8: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 100,195 |
Reported balance
After 2026-07-07 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2026-07-07 · Conversion · Acquired 100,195 · Balance 100,195 F8: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 19,382 |
Reported balance
After 2026-07-07 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-07-07 · Conversion · Acquired 19,382 · Balance 19,382 F8: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-07 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2026-07-07 · Sale · Disposed 122,188 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-07 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2026-07-07 · Sale · Disposed 2,907 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-07 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2026-07-07 · Sale · Disposed 100,195 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-07 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2026-07-07 · Sale · Disposed 19,382 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 90,640 |
Reported balance
After 2026-07-09 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2026-07-09 · Conversion · Acquired 90,640 · Balance 90,640 F8: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 2,156 |
Reported balance
After 2026-07-09 transaction · row 10
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 10 · 2026-07-09 · Conversion · Acquired 2,156 · Balance 2,156 F8: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 74,325 |
Reported balance
After 2026-07-09 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2026-07-09 · Conversion · Acquired 74,325 · Balance 74,325 F8: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 14,378 |
Reported balance
After 2026-07-09 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2026-07-09 · Conversion · Acquired 14,378 · Balance 14,378 F8: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 2,792 |
Reported balance
After 2026-07-09 transaction · row 13
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 13 · 2026-07-09 · Sale · Disposed 87,848 · Balance 2,792 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 66 |
Reported balance
After 2026-07-09 transaction · row 14
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 14 · 2026-07-09 · Sale · Disposed 2,090 · Balance 66 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 2,289 |
Reported balance
After 2026-07-09 transaction · row 15
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 15 · 2026-07-09 · Sale · Disposed 72,036 · Balance 2,289 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 443 |
Reported balance
After 2026-07-09 transaction · row 16
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 16 · 2026-07-09 · Sale · Disposed 13,935 · Balance 443 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-09 transaction · row 17
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 17 · 2026-07-09 · Sale · Disposed 2,792 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-09 transaction · row 18
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 18 · 2026-07-09 · Sale · Disposed 66 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-09 transaction · row 19
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 19 · 2026-07-09 · Sale · Disposed 2,289 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-09 transaction · row 20
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 20 · 2026-07-09 · Sale · Disposed 443 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 3,094,820 |
Reported balance
After 2026-07-07 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2026-07-07 · Conversion · Disposed 122,188 · Balance 3,094,820 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 73,638 |
Reported balance
After 2026-07-07 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2026-07-07 · Conversion · Disposed 2,907 · Balance 73,638 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 2,537,790 |
Reported balance
After 2026-07-07 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2026-07-07 · Conversion · Disposed 100,195 · Balance 2,537,790 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 490,910 |
Reported balance
After 2026-07-07 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2026-07-07 · Conversion · Disposed 19,382 · Balance 490,910 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 3,004,180 |
Reported balance
After 2026-07-09 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2026-07-09 · Conversion · Disposed 90,640 · Balance 3,004,180 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 71,482 |
Reported balance
After 2026-07-09 transaction · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · 2026-07-09 · Conversion · Disposed 2,156 · Balance 71,482 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 2,463,465 |
Reported balance
After 2026-07-09 transaction · row 27
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 27 · 2026-07-09 · Conversion · Disposed 74,325 · Balance 2,463,465 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 476,532 |
Reported balance
After 2026-07-09 transaction · row 28
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 28 · 2026-07-09 · Conversion · Disposed 14,378 · Balance 476,532 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
F7: See Exhibit 99.1
F8: See Exhibit 99.1
F9: See Exhibit 99.1
F10: See Exhibit 99.1
F11: See Exhibit 99.1
F12: See Exhibit 99.1
SentinelOne, Inc.
Report date April 01, 2024 · Filed April 04, 2024
Jointly reported with Insight Holdings Group, LLC, Insight Venture Associates X, L.P., Insight Venture Associates X, Ltd., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X (Co-Investors), L.P., Insight Venture Partners X, L.P.
Section 16 reporting ended · disclosed 2024-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,933,556 |
Reported balance
After 2024-04-01 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-04-01 · Conversion · Acquired 3,933,556 · Balance 3,933,556 F1: See Exhibit 99.1 F2: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,225,563 |
Reported balance
After 2024-04-01 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-04-01 · Conversion · Acquired 3,225,563 · Balance 3,225,563 F1: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 623,954 |
Reported balance
After 2024-04-01 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-04-01 · Conversion · Acquired 623,954 · Balance 623,954 F1: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 93,593 |
Reported balance
After 2024-04-01 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-04-01 · Conversion · Acquired 93,593 · Balance 93,593 F1: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,887,664 |
Reported balance
After 2024-04-01 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2024-04-01 · Sale · Disposed 45,892 · Balance 3,887,664 F6: See Exhibit 99.1 F2: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,187,931 |
Reported balance
After 2024-04-01 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2024-04-01 · Sale · Disposed 37,632 · Balance 3,187,931 F6: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 616,675 |
Reported balance
After 2024-04-01 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2024-04-01 · Sale · Disposed 7,279 · Balance 616,675 F6: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 92,501 |
Reported balance
After 2024-04-01 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2024-04-01 · Sale · Disposed 1,092 · Balance 92,501 F6: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 8,621,691 |
Reported balance
After 2024-04-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-04-01 · Conversion · Disposed 3,933,556 · Balance 8,621,691 F1: See Exhibit 99.1 F2: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 7,069,890 |
Reported balance
After 2024-04-01 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-04-01 · Conversion · Disposed 3,225,563 · Balance 7,069,890 F1: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 1,367,601 |
Reported balance
After 2024-04-01 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2024-04-01 · Conversion · Disposed 623,954 · Balance 1,367,601 F1: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 205,141 |
Reported balance
After 2024-04-01 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2024-04-01 · Conversion · Disposed 93,593 · Balance 205,141 F1: See Exhibit 99.1 F5: See Exhibit 99.1 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
nCino, Inc.
Report date December 09, 2024 · Filed December 11, 2024
Jointly reported with Insight Holdings Group, LLC, Insight SN Holdings 2, LLC, Insight SN Holdings, LLC, Insight Venture Associates X, L.P., Insight Venture Associates X, Ltd., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X, L.P., Insight Venture Partners X (Co-Investors), L.P.
Section 16 reporting ended · disclosed 2024-12-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 340,399 |
Reported balance
After 2024-12-09 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-12-09 · Sale · Disposed 21,892 · Balance 340,399 F1: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 999,315 |
Reported balance
After 2024-12-09 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-12-09 · Sale · Disposed 37,277 · Balance 999,315 F1: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 193,308 |
Reported balance
After 2024-12-09 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-12-09 · Sale · Disposed 7,211 · Balance 193,308 F1: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 907,255 |
Reported balance
After 2024-12-09 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-12-09 · Sale · Disposed 24,649 · Balance 907,255 F1: See Exhibit 99.1 F6: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 286,590 |
Reported balance
After 2024-12-10 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2024-12-10 · Sale · Disposed 53,809 · Balance 286,590 F2: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 907,693 |
Reported balance
After 2024-12-10 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2024-12-10 · Sale · Disposed 91,622 · Balance 907,693 F2: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 175,585 |
Reported balance
After 2024-12-10 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2024-12-10 · Sale · Disposed 17,723 · Balance 175,585 F2: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 846,672 |
Reported balance
After 2024-12-10 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2024-12-10 · Sale · Disposed 60,583 · Balance 846,672 F2: See Exhibit 99.1 F6: See Exhibit 99.1 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 8,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 16 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 8,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 46,060 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 15 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 46,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 1,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 14 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 1,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 56,171 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 13 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 56,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 17,776 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 34 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 719,687 Underlying: Class A Common Stock · 17,776 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 91,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 33 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,720,462 Underlying: Class A Common Stock · 91,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 2,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 32 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 107,953 Underlying: Class A Common Stock · 2,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 112,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 31 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 4,537,082 Underlying: Class A Common Stock · 112,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 8,118 | $71.20 | $577,996.73 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 12 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 41,964 | $71.20 | $2,987,811.62 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 11 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 1,217 | $71.20 | $86,649.67 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 10 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 51,176 | $71.20 | $3,643,700.49 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 9 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 9,658 | $70.75 | $683,282.25 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 8 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 8,118 F14 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 49,929 | $70.75 | $3,532,366.91 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 7 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 41,964 F14 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 1,449 | $70.75 | $102,513.56 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 6 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 1,217 F14 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 60,888 | $70.75 | $4,307,692.05 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 5 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 51,176 F14 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 17,776 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 4 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 17,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 91,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 3 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 91,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 2,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 2 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 2,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 112,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 1 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 112,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 5,195 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · derivative · entry 12 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 737,463 Underlying: Class A Common Stock · 5,195 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 26,856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · derivative · entry 11 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,812,355 Underlying: Class A Common Stock · 26,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · derivative · entry 10 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 110,619 Underlying: Class A Common Stock · 779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 32,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · derivative · entry 9 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 4,649,146 Underlying: Class A Common Stock · 32,751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 5,195 | $70.36 | $365,518.12 |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · nonDerivative · entry 8 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F10 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 26,856 | $70.36 | $1,889,577.42 |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · nonDerivative · entry 7 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F10 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 779 | $70.36 | $54,810.13 |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · nonDerivative · entry 6 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F10 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 32,751 | $70.36 | $2,304,347.26 |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · nonDerivative · entry 5 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F10 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 5,195 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · nonDerivative · entry 4 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 5,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 26,856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · nonDerivative · entry 3 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 26,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · nonDerivative · entry 2 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 16, 2026 Filed Jun 19, 2026 01:52 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 32,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000667 · form4.xml · nonDerivative · entry 1 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 32,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 131,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · derivative · entry 12 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 742,658 Underlying: Class A Common Stock · 131,057 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F5 · price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F8 · derivative.exercise_date: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F8 · derivative.expiration_date: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F4 · ownership.nature: Held directly by Insight Venture Partners (Delaware) X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 677,508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · derivative · entry 11 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,839,211 Underlying: Class A Common Stock · 677,508 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F5 · price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F8 · derivative.exercise_date: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F8 · derivative.expiration_date: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F3 · ownership.nature: Held directly by Insight Venture Partners (Cayman) X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 19,659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · derivative · entry 10 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 111,398 Underlying: Class A Common Stock · 19,659 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F5 · price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F8 · derivative.exercise_date: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F8 · derivative.expiration_date: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F2 · ownership.nature: Held directly by Insight Venture Partners X (Co-Investors), L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 826,216 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · derivative · entry 9 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,681,897 Underlying: Class A Common Stock · 826,216 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F5 · price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F8 · derivative.exercise_date: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F8 · derivative.expiration_date: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · ownership.nature: Held directly by Insight Venture Partners X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 131,057 | $47.76 | $6,259,282.32 |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · nonDerivative · entry 8 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F4 · ownership.nature: Held directly by Insight Venture Partners (Delaware) X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 677,508 | $47.76 | $32,357,782.08 |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · nonDerivative · entry 7 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F3 · ownership.nature: Held directly by Insight Venture Partners (Cayman) X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 19,659 | $47.76 | $938,913.84 |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · nonDerivative · entry 6 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F2 · ownership.nature: Held directly by Insight Venture Partners X (Co-Investors), L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 826,216 | $47.76 | $39,460,076.16 |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · nonDerivative · entry 5 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · ownership.nature: Held directly by Insight Venture Partners X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 131,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · nonDerivative · entry 4 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 131,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F4 · ownership.nature: Held directly by Insight Venture Partners (Delaware) X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 677,508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · nonDerivative · entry 3 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 677,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F3 · ownership.nature: Held directly by Insight Venture Partners (Cayman) X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 19,659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · nonDerivative · entry 2 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 19,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F2 · ownership.nature: Held directly by Insight Venture Partners X (Co-Investors), L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 826,216 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-25-001409 · form4.xml · nonDerivative · entry 1 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 826,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: On December 1, 2025, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · ownership.nature: Held directly by Insight Venture Partners X, L.P. F6 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F7 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| May 23, 2025 Filed May 27, 2025 22:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 1,250,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077934 · ownership.xml · derivative · entry 8 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 11,029,604 Underlying: Class A Common Stock · 1,250,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F2 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F3 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. F4 · ownership.nature: Consists of (i) 624,242 shares of Class B Common Stock held by IVP X were converted into 624,242 shares of Class A Common Stock, (ii) 511,886 shares of Class B Common Stock held by IVP Cayman X were converted into 511,886 shares of Class A Common Stock, (iii) 99,019 shares of Class B Common Stock held by IVP Delaware X were converted into 99,019 shares of Class A Common Stock, and (iv) 14,853 shares of Class B Common Stock held by IVP X Co-Investors were converted into 14,853 shares of Class A Common Stock, and such shares of Class A Common Stock were sold in connection with the Issuer's initial public offering. F6 · ownership.nature: Following the transactions reported in this Form 4, (i) 5,508,113 shares of Class B Common Stock are held by IVP X, (ii) 4,516,719 shares of Class B Common Stock are held by IVP Cayman X, (iii) 873,715 shares of Class B Common Stock are held by IVP Delaware X, and (iv) 131,057 shares of Class B Common Stock are held by IVP X Co-Investors. Read SEC document |
| May 23, 2025 Filed May 27, 2025 22:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | OtherClass B Common Stock · Derivative | 12,279,604 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077934 · ownership.xml · derivative · entry 7 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 12,279,604 Underlying: Class A Common Stock · 12,279,604 shares Expires not disclosed F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F2 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F3 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. F5 · ownership.nature: Consists of (i) 6,132,355 shares held by IVP X, (ii) 5,028,605 shares held by IVP Cayman X, (iii) 972,734 shares held by IVP Delaware X, and (iv) 145,910 shares held by IVP X Co-Investors. Read SEC document |
| May 23, 2025 Filed May 27, 2025 22:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | OtherSeries D Preferred Stock · Derivative | 819,106 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077934 · ownership.xml · derivative · entry 6 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 819,106 shares Expires not disclosed F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F2 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F3 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| May 23, 2025 Filed May 27, 2025 22:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | OtherSeries C-1 Preferred Stock · Derivative | 451,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077934 · ownership.xml · derivative · entry 5 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 451,723 shares Expires not disclosed F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F2 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F3 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| May 23, 2025 Filed May 27, 2025 22:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | OtherSeries C Preferred Stock · Derivative | 2,026,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077934 · ownership.xml · derivative · entry 4 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 2,026,592 shares Expires not disclosed F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F2 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F3 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
| May 23, 2025 Filed May 27, 2025 22:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | OtherSeries B Preferred Stock · Derivative | 8,982,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077934 · ownership.xml · derivative · entry 3 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 8,982,183 shares Expires not disclosed F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F2 · ownership.nature: Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities. F3 · ownership.nature: Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.